US Patent 11559515 Indole compounds and analogues thereof
Patent 11559515 was granted and assigned to BioCryst Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11559515 Indole compounds and analogues thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.